Product Information

OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0551 per EA under NDC 64980066503. Its NADAC has been published 69 times since Apr 30, 2025.

FDA first approved this application on May 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 5 MG TAB

olmesartan medoxomil
$0.0551per EA

Strength

5 mg/1

NDC

64980066503

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA208659

FDA Approved

5/18/2020

TE Code

AB

On Market Since

10/7/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 69 times since Apr 30, 2025, and over the history we have for it it has declined 13.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0551 per EA
All-time high$0.0663 (Jul 16, 2025)
All-time low$0.0551 (Aug 19, 2026)
52-week high$0.0610
52-week low$0.0551
Median price$0.0586
Average price$0.0597
Largest weekly change-6.5% (Aug 20, 2025)
Weeks tracked69
Tracking sinceApr 30, 2025

Price History

1W

-1.4%

1M

-2.1%

3M

-4.5%

6M

-4.3%

1Y

-9.7%

3Y

N/A

5Y

N/A

All

-13.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.0551 per EA (NDC 64980066503), effective Aug 19, 2026.

How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 13.5%. It has been tracked across 69 weekly CMS publications since Apr 30, 2025.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?

Since Apr 30, 2025, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0663 (Jul 16, 2025), with a median of $0.0586 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?

OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 64980066503) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.